Royal Bank of Canada’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $123K | Sell |
|
|||||
|
2025
Q2 | $5.55M | Buy |
|
|||||
|
2025
Q1 | $22K | Sell |
|
|||||
|
2024
Q4 | $48K | Buy |
|
|||||
|
2024
Q3 | $30K | Sell |
|
|||||
|
2024
Q2 | $38K | Buy |
|
|||||
|
2024
Q1 | $26K | Sell |
|
|||||
|
2023
Q4 | $192K | Buy |
|
|||||
|
2023
Q3 | $83K | Buy |
|
|||||
|
2023
Q2 | $68K | Buy |
|
|||||
|
2023
Q1 | $53K | Sell |
|
|||||
|
2022
Q4 | $123K | Buy |
|
|||||
|
2022
Q3 | $67K | Buy |
|
|||||
|
2022
Q2 | $4K | Sell |
|
|||||
|
2022
Q1 | $124K | Sell |
|
|||||
|
2021
Q4 | $275K | Buy |
|
|||||
|
2021
Q3 | $157K | Sell |
|
|||||
|
2021
Q2 | $364K | Buy |
|
|||||
|
2021
Q1 | $436K | Sell |
|
|||||
|
2020
Q4 | $393K | Sell |
|
|||||
|
2020
Q3 | $337K | Sell |
|
|||||
|
2020
Q2 | $513K | Sell |
|
|||||
|
2020
Q1 | $580K | Buy |
|
|||||
|
2019
Q4 | $614K | Buy |
|
|||||
|
2019
Q3 | $382K | Buy |
|
|||||
|
2019
Q2 | $305K | Buy |
|
|||||
|
2019
Q1 | $417K | Buy |
|
|||||
|
2018
Q4 | $460K | Sell |
|
|||||
|
2018
Q3 | $609K | Buy |
|
|||||
|
2018
Q2 | $403K | Buy |
|
|||||
|
2018
Q1 | $404K | Buy |
|
|||||
|
2017
Q4 | $380K | Sell |
|
|||||
|
2017
Q3 | $535K | Buy |
|
|||||
|
2017
Q2 | $390K | Sell |
|
|||||
|
2017
Q1 | $385K | Sell |
|
|||||
|
2016
Q4 | $388K | Sell |
|
|||||
|
2016
Q3 | $787K | Buy |
|
|||||
|
2016
Q2 | $232K | Sell |
|
|||||
|
2016
Q1 | $197K | Hold |
|
|||||
|
2015
Q4 | $172K | Sell |
|
|||||
|
2015
Q3 | $116K | Hold |
|
|||||
|
2015
Q2 | $137K | Buy |
|
|||||
|
2015
Q1 | $10K | Sell |
|
|||||
|
2014
Q4 | $18K | Sell |
|
|||||
|
2014
Q3 | $255K | Buy |
|
|||||
|
2014
Q2 | $27K | Buy |
|